Live Analyst Rating Changes 1506 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Shinichiro Muraoka
MS
Shinichiro Muraoka
Morgan Stanley
Wall Street Analyst
Not yet ranked — too few measurable calls.
0%
Success Rate
-8.3%
Average Return
0 of 1 calls profitable · +4.6% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 0% of Shinichiro Muraoka's ratings turned a profit when each position was held for 1 year — averaging -8.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

7 Buy 4 Hold 1 Sell
Shinichiro's Stock Coverage 13 ratings · 2026-06-18
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
JP:4887
SAWAI GROUP HOLDINGS Co., Ltd.
 Jun 12, 2026 HOLD Hold
+21.9% avg upside
1 analyst
$2000.00
21.92% Upside
 ·
JP:4502
Takeda Pharmaceutical Co
 Jun 03, 2026 BUY Strong Buy
-1.0% avg upside
6 analysts
$6300.00
26.09% Upside
 ·
JP:4578
Otsuka Holdings Co
 Apr 30, 2026 BUY Strong Buy
+15.2% avg upside
4 analysts
$14100.00
29.19% Upside
 ·
JP:4151
Kyowa Kirin Co
 Mar 06, 2026 SELL Sell
-14.6% avg upside
4 analysts
$1700.00
31.78% Downside
 ·
JP:4568
Daiichi Sankyo Company
 Nov 21, 2025 BUY Strong Buy
+60.2% avg upside
5 analysts
$4950.00
83.19% Upside
 ·
JP:4506
Sumitomo Dainippon Pharma Co
 Aug 22, 2025 HOLD Strong Buy
+30.0% avg upside
3 analysts
$1350.00
10.28% Downside
 ·
JP:4592
SanBio Co
 Jul 02, 2025 HOLD Hold
+93.8% avg upside
1 analyst
$2100.00
93.76% Upside
 ·
JP:4507
Shionogi & Co
 May 30, 2025 HOLD Buy
-4.3% avg upside
4 analysts
$2750.00
3.05% Downside
 ·
JP:4503
Astellas Pharma
 May 30, 2025 HOLD Buy
-5.1% avg upside
4 analysts
$1500.00
31.31% Downside
 ·
JP:4523
Eisai Co
 May 29, 2025 HOLD Hold
+9.4% avg upside
4 analysts
$4100.00
4.00% Upside
 ·
JP:4516
Nippon Shinyaku Co., Ltd.
 May 28, 2025 HOLD Hold
-7.9% avg upside
3 analysts
$3800.00
5.10% Downside
 ·
JP:4519
Chugai Pharmaceutical Co
 Oct 25, 2024 BUY Strong Buy
+19.6% avg upside
4 analysts
$8050.00
6.53% Upside
 ·
TAK
Takeda Pharmaceutical Company
 Oct 06, 2021 HOLD Buy
+25.5% avg upside
4 analysts
 — -8.3%
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Shinichiro Muraoka — Frequently Asked Questions
How accurate are Shinichiro Muraoka's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Shinichiro's ratings were profitable over a one-year hold, with an average return of -8.3% per rating, or +4.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Shinichiro ranked on 13Foresight?
Shinichiro Muraoka is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Shinichiro cover?
Shinichiro most recently has ratings on JP:4887, JP:4502, JP:4578, JP:4151, JP:4568, JP:4506, JP:4592, JP:4507, JP:4503, JP:4523, JP:4516, JP:4519 and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.